Innominds, a U.S.-based digital transformation and product engineering firm, in partnership with Hyderabad-based SCIINV Biosciences launched AMRx, a sophisticated AI/ML-driven digital diagnostic device designed to combat the rising menace of antimicrobial resistance (AMR).
The device would revolutionise the detection and remedy of antibiotic-resistant infections with out the necessity for conventional cultures. It was a culture-free companion diagnostic device that utilises AI/ML to predict Urinary Tract Infections (UTIs) and decide antibiotic resistance patterns primarily based on affected person scientific historical past, mentioned the corporate.
‘’Traditional strategies are falling brief within the race towards wildfire-like proliferation of Antimicrobial Resistance. It’s crucial to harness superior digital applied sciences (AI/ML/DL) to develop various diagnostic instruments and therapeutic options,’‘ said Prof Ranga Reddy Burri, Advisor, SCIINV Biosciences, and President, Infection Control Academy of India.
Some 8,000 patients (from seven tertiary care hospitals) suspected of Urinary Tract Infection (UTI) were part of the initial series of AMR tests conducted. The tool can capture 170 clinical parameters of a patient’s scientific historical past, presenting signs and present complaints.
